PharmaNutrients was an early pioneer of the Intel Inside ® concept to assure the quality, manufacturing processes and testing regime required in supporting branded nutritional supplement ingredients.PharmaNutrients has an expertise in the in-license, branding and global commercialization of novel nutritional compounds, beginning with licensing intellectual property for the use of chitosan as a lipid binder (Dr. Ivan Furda patent 5,932,561). PharmaNutrients subsequently pioneered the commercialization of CLA (Conjugated Linoleic Acid) with licensed intellectual property from the University of Wisconsin, Madison (WARF patents including 6,743,931).The Company complements its support of our international clients with cGMP (Current Good Manufacturing Practice), procurement and supply chain management.
From our founding in 1993 through today, the Absorbitol brand chitosan-based complex remains a leader in its category. It is available only in select markets.
By creating Tonalin® CLA, PharmaNutrients brought the first CLA to market and established a new category in body composition. PharmaNutrients divested of the brand to Natural ASA of Norway, and the business was eventually acquired by BASF of Germany.
With the intention to develop new applications for CLA, PharmaNutrients continued to support novel applications and research. The company developed CLAOne, and subsequently divested that business to Lipid Nutrition of the Netherlands.
PharmaNutrients’ systems and procedures assure quality management over an international network of manufacturing partners and independent testing laboratories throughout Europe, Asia and the Americas, facilitating the complexities of sourcing.
Our mission remains to provide quality products, manufactured under GMP conditions, that meet the demanding requirements of Japanese and European clients.
Copyrights © 2019 All Rights Reserved by PharmaNutrients
37 Sherwood Terrace, Suites 109-110 Lake Bluff, IL 60044